CaltechAUTHORS
  A Caltech Library Service

Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo

Azizian, Nancy G. and Sullivan, Delaney K. and Nie, Litong and Pardo, Sammy and Molleur, Dana and Chen, Junjie and Weintraub, Susan T. and Li, Yulin (2021) Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo. Journal of Proteome Research, 20 (1). pp. 858-866. ISSN 1535-3893. https://resolver.caltech.edu/CaltechAUTHORS:20200528-070157562

[img] PDF - Submitted Version
Creative Commons Attribution Non-commercial No Derivatives.

1670Kb
[img]
Preview
PDF (Figures) - Supplemental Material
See Usage Policy.

4Mb
[img] MS Excel (Tables) - Supplemental Material
See Usage Policy.

3002Kb

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20200528-070157562

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers. Dissecting the tumor cell proteome from that of the non-tumor cells in the PDAC tumor bulk is critical for tumorigenesis studies, biomarker discovery, and development of therapeutics. However, investigating the tumor cell proteome has proven evasive due to the tumor’s extremely complex cellular composition. To circumvent this technical barrier, we have combined bioorthogonal noncanonical amino acid tagging (BONCAT) and data-independent acquisition mass spectrometry (DIA-MS) in an orthotopic PDAC model to specifically identify the tumor cell proteome in vivo. Utilizing the tumor cell-specific expression of a mutant tRNA synthetase transgene, this approach provides tumor cells with the exclusive ability to incorporate an azide-bearing methionine analogue into newly synthesized proteins. The azide-tagged tumor cell proteome is subsequently enriched and purified via a bioorthogonal reaction and then identified and quantified using DIA-MS. Applying this workflow to the orthotopic PDAC model, we have identified thousands of proteins expressed by the tumor cells. Furthermore, by comparing the tumor cell and tumor bulk proteomes, we showed that the approach can distinctly differentiate proteins produced by tumor cells from those of non-tumor cells within the tumor microenvironment. Our study, for the first time, reveals the tumor cell proteome of PDAC under physiological conditions, providing broad applications for tumorigenesis, therapeutics, and biomarker studies in various human cancers.


Item Type:Article
Related URLs:
URLURL TypeDescription
https://doi.org/10.1021/acs.jproteome.0c00666DOIArticle
https://doi.org/10.1101/2020.05.25.113670DOIDiscussion Paper
ORCID:
AuthorORCID
Chen, Junjie0000-0002-1493-2189
Li, Yulin0000-0003-3479-9909
Additional Information:© 2020 American Chemical Society. Received: August 27, 2020; Published: December 8, 2020. We greatly appreciate Dr. Marina Pasca di Magliano for generously providing the murine pancreatic cancer cell line (4292). We would also like to thank members of David Tirrell and Erin Schuman labs for sharing protocols on BONCAT procedures. Mass spectrometry analyses were conducted in the Mass Spectrometry Laboratory at the University of Texas Health Science Center at San Antonio. This work was supported in part by NIH K22CA207598 (Y.L.), CPRIT RP200472 (Y.L.), and NIH GM008042 (D.K.S.; UCLA-Caltech Medical Scientist Training Program). Support from the University of Texas System Proteomics Core Network for the purchase of the Lumos mass spectrometer is gratefully acknowledged. Author Contributions: N.G.A., S.T.W., and Y.L. designed the study and developed the approach. N.G.A. carried out all cell culture, animal studies, and click chemistry experiments. S.P. and D.M. conducted the DIA-MS analysis. D.K.S., S.T.W., L.N., N.G.A., and Y.L. analyzed the data. J.C. advised the study. N.G.A. and Y.L. wrote and S.T.W. edited the manuscript. All authors reviewed and approved the manuscript. The authors declare no competing financial interest.
Funders:
Funding AgencyGrant Number
NIHK22CA207598
Cancer Prevention and Research Institute of TexasRP200472
NIH Predoctoral FellowshipGM008042
UCLA-Caltech Medical Scientist Training ProgramUNSPECIFIED
University of TexasUNSPECIFIED
Subject Keywords:pancreatic ductal adenocarcinoma (PDAC), bioorthogonal noncanonical amino acid tagging (BONCAT), data-independent acquisition mass spectrometry (DIA-MS), methionyl-tRNA synthetase (MetRS), azidonorleucine (ANL), patient-derived xenografts (PDX)
Issue or Number:1
Record Number:CaltechAUTHORS:20200528-070157562
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20200528-070157562
Official Citation:Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer In Vivo Nancy G. Azizian, Delaney K. Sullivan, Litong Nie, Sammy Pardo, Dana Molleur, Junjie Chen, Susan T. Weintraub, and Yulin Li. Journal of Proteome Research 2021 20 (1), 858-866; DOI: 10.1021/acs.jproteome.0c00666
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:103506
Collection:CaltechAUTHORS
Deposited By: Tony Diaz
Deposited On:28 May 2020 16:26
Last Modified:05 Jan 2021 18:38

Repository Staff Only: item control page